Last reviewed · How we verify

Kybella Flanks — Competitive Intelligence Brief

Kybella Flanks (Kybella Flanks) competitive landscape: 1 comparator, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Lipid-dissolving agent. Area: Dermatology / Aesthetics.

marketed Lipid-dissolving agent Adipocyte cell membrane Dermatology / Aesthetics Small molecule Live · refreshed every 30 min

Target snapshot

Kybella Flanks (Kybella Flanks) — Beer, Kenneth R., M.D., PA. Kybella (deoxycholic acid) destroys fat cells through a naturally occurring bile acid that disrupts cell membranes, leading to permanent reduction of submental fat.

Comparator set (1 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
Kybella Flanks TARGET Kybella Flanks Beer, Kenneth R., M.D., PA marketed Lipid-dissolving agent Adipocyte cell membrane
Sodium Deoxycholate Sodium Deoxycholate Goldman, Butterwick, Fitzpatrick and Groff marketed Lipid-dissolving agent / Lipolytic agent Adipocyte cell membrane

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Lipid-dissolving agent class)

  1. Beer, Kenneth R., M.D., PA · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Kybella Flanks — Competitive Intelligence Brief. https://druglandscape.com/ci/kybella-flanks. Accessed 2026-05-14.

Build your own brief

Pick any drug + add comparators: